Recent Finacing
Recent Raise
Precision Biologics develops tumor-specific monoclonal antibodies and diagnostics from a proprietary library of surgically removed human tumors; its lead antibody is in Phase 2 trials for pancreatic cancer.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor